-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409

Benzinga·10/28/2026 11:47:58
Listen to the news
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.